The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.

Latest News

Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast

March 17th 2025

While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.

New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging

March 13th 2025

AI and bpMRI for csPCa Detection: What a New Meta-Analysis Reveals
AI and bpMRI for csPCa Detection: What a New Meta-Analysis Reveals

March 10th 2025

Imaging Findings Reveal 49 Percent Improvement in Progression-Free Survival for Ivonescimab in NSCLC Patients
Imaging Findings Reveal 49 Percent Improvement in Progression-Free Survival for Ivonescimab in NSCLC Patients

March 7th 2025

Is Ultrasound or MRI More Effective for Diagnosing Peripheral Nerve Disorders in the Upper Extremities?
Is Ultrasound or MRI More Effective for Diagnosing Peripheral Nerve Disorders in the Upper Extremities?

March 6th 2025

Latest CME Events & Activities

Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®

View More

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Register Now!

Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment

April 4, 2025 | New York, NY & Virtual

Register Now!

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

View More

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Register Now!

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

View More

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 12-14, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

43rd Annual Miami Breast Cancer Conference®

March 5-8, 2026

Register Now!

More News

© 2025 MJH Life Sciences

All rights reserved.